These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17682895)

  • 21. Experimental and clinical investigations of the use of carbon fiber sutures in equine tendon repair.
    Brown MP; Pool RR
    J Am Vet Med Assoc; 1983 May; 182(9):956-66. PubMed ID: 6343320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superficial digital flexor tendon healing: ultrasonographic evaluation of therapies.
    Reef VB
    Vet Clin North Am Equine Pract; 2001 Apr; 17(1):159-78, vii-viii. PubMed ID: 11488042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fetal derived embryonic-like stem cells improve healing in a large animal flexor tendonitis model.
    Watts AE; Yeager AE; Kopyov OV; Nixon AJ
    Stem Cell Res Ther; 2011 Jan; 2(1):4. PubMed ID: 21272343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Firing of tendons.
    Borthwick BR
    Vet Rec; 1983 Oct; 113(17):405. PubMed ID: 6649371
    [No Abstract]   [Full Text] [Related]  

  • 25. Harnessing the stem cell for the treatment of tendon injuries: heralding a new dawn?
    Smith RK; Webbon PM
    Br J Sports Med; 2005 Sep; 39(9):582-4. PubMed ID: 16118291
    [No Abstract]   [Full Text] [Related]  

  • 26. Lesions of the superficial flexor tendon in race horses. A microangiographic and histopathologic study.
    Strömberg B; Tufvesson G
    Clin Orthop Relat Res; 1969; 62():113-23. PubMed ID: 5813188
    [No Abstract]   [Full Text] [Related]  

  • 27. Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons.
    Schnabel LV; Lynch ME; van der Meulen MC; Yeager AE; Kornatowski MA; Nixon AJ
    J Orthop Res; 2009 Oct; 27(10):1392-8. PubMed ID: 19350658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wound management in horses.
    Britton JW
    J Am Vet Med Assoc; 1970 Dec; 157(11):1585-9. PubMed ID: 5530360
    [No Abstract]   [Full Text] [Related]  

  • 29. Mesenchymal stem cell licensing: enhancing MSC function as a translational approach for the treatment of tendon injury.
    Koch DW; Schnabel LV
    Am J Vet Res; 2023 Sep; 84(10):1-8. PubMed ID: 37669745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of sprained tendons in horses with carbon fibre implants.
    Littlewood HF
    Vet Rec; 1979 Sep; 105(10):223-4. PubMed ID: 552716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computerised analysis of standardised ultrasonographic images to monitor the repair of surgically created core lesions in equine superficial digital flexor tendons following treatment with intratendinous platelet rich plasma or placebo.
    Bosch G; René van Weeren P; Barneveld A; van Schie HT
    Vet J; 2011 Jan; 187(1):92-8. PubMed ID: 19932036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Firing of horses.
    Donaldson RS
    Vet Rec; 1979 Aug; 105(8):173-4. PubMed ID: 516355
    [No Abstract]   [Full Text] [Related]  

  • 33. Regulatory considerations related to stem cell treatment in horses.
    Yingling GL; Nobert KM
    J Am Vet Med Assoc; 2008 Jun; 232(11):1657-61. PubMed ID: 18518806
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the pathogenesis of equine tendonitis following collagenase injury.
    Williams IF; McCullagh KG; Goodship AE; Silver IA
    Res Vet Sci; 1984 May; 36(3):326-38. PubMed ID: 6087432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility and safety of intrathecal transplantation of autologous bone marrow mesenchymal stem cells in horses.
    Maia L; da Cruz Landim-Alvarenga F; Taffarel MO; de Moraes CN; Machado GF; Melo GD; Amorim RM
    BMC Vet Res; 2015 Mar; 11():63. PubMed ID: 25879519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new clinical approach: use of blood-derived stem cells (BDSCs) for superficial digital flexor tendon injuries in horses.
    Marfe G; Rotta G; De Martino L; Tafani M; Fiorito F; Di Stefano C; Polettini M; Ranalli M; Russo MA; Gambacurta A
    Life Sci; 2012 Jun; 90(21-22):825-30. PubMed ID: 22480518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Can you regain your youth?'--the real potential of stem cell technology.
    Smith RK
    Equine Vet J; 2010 Jan; 42(1):2-4. PubMed ID: 20121905
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of autologous adipose tissue-derived mesenchymal stem cells on neovascularization of artificial equine tendon lesions.
    Conze P; van Schie HT; van Weeren R; Staszyk C; Conrad S; Skutella T; Hopster K; Rohn K; Stadler P; Geburek F
    Regen Med; 2014; 9(6):743-57. PubMed ID: 25431911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of recombinant equine growth hormone on the biomechanical properties of healing superficial digital flexor tendons in horses.
    Dowling BA; Dart AJ; Hodgson DR; Rose RJ; Walsh WR
    Vet Surg; 2002; 31(4):320-4. PubMed ID: 12094345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-based therapies for tendon and ligament injuries.
    Alves AG; Stewart AA; Dudhia J; Kasashima Y; Goodship AE; Smith RK
    Vet Clin North Am Equine Pract; 2011 Aug; 27(2):315-33. PubMed ID: 21872761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.